-
programs within UMGCCC including, Experimental Therapeutics, Tumor Immunology & Immunotherapy, Molecular and Structural Biology, and Hormone Related Cancers. The co-leader should ideally be an NIH funded
-
Co-Leader, Hormone Responsive Cancers - (240000P6) The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) is accepting nominations/applications for co-leader
-
Office Manager - (240000HH) The University of Maryland Greenebaum Comprehensive Cancer Center (UMGCCC) has an exciting opportunity for an Office Manager to provide administrative and procedural
-
medical genetics and genomics, especially in cancer, cardiovascular or neurological genetics, metabolic disease, or computation health are encouraged to apply, although any experienced and qualified
-
defects, fetal programming, placental development and inflammation, ovarian cancer, and substance abuse. Our mission is to have a meaningful impact on the healthcare in our communities and our research
-
candidate’s experience. Our research focuses on structural birth defects, fetal programming, placental development and inflammation, ovarian cancer, and substance abuse. Our mission is to have a meaningful
-
Postdoctoral Fellow/Research Associate/Data Scientist in Cancer Epidemiology Research - (210000E1) University of Maryland School of Medicine Department of Epidemiology and Public Health, Division
-
growth · Opportunities to interact with trainees across all levels Features: · Pediatric component of an expanded NCI Comprehensive Cancer Center · Access to centralized research
-
accredited by the American College of Surgeons’ National Accreditation Program for Breast Centers (NAPBC) and the center’s service offerings include medical oncology, cancer surgery, radiation oncology
-
dermatology and acute cancer care. An interest in participating in clinical trials is also important for this position. Protected time will be available to develop research interests. Candidates with active